Results 141 to 150 of about 4,448 (184)

Intellectual disability and neurogenesis defects associated with increased turnover of an O-GlcNAcase variant

open access: yes, 2023
Authier F   +9 more
europepmc   +1 more source

Extracellular Vesicle-Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion. [PDF]

open access: yesCancer Res
Zhao J   +18 more
europepmc   +1 more source

Radiosynthesis and evaluation of a carbon-11 labeled PET ligand for imaging of O-GlcNAcase. [PDF]

open access: yesAm J Nucl Med Mol Imaging
Li Y   +15 more
europepmc   +1 more source

Erratum: “Isoforms of Human O-GlcNAcase Show Distinct Catalytic Efficiencies” [PDF]

open access: yesBiochemistry (Moscow), 2010
Jing Li   +6 more
openaire   +1 more source

In vivo quantification of [<sup>11</sup>C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcase. [PDF]

open access: yesJ Cereb Blood Flow Metab
Bolin M   +8 more
europepmc   +1 more source

Modification of the Thioglycosyl-Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors. [PDF]

open access: yesACS Med Chem Lett, 2018
Shen S   +6 more
europepmc   +1 more source

Development of chemical tools for studying human O-GlcNAcase activity

open access: yes, 2015
In recent years, the post-translational modification of nuclear and cytoplasmic proteins with O-linked N-acetylglucosamine (O-GlcNAc) has emerged as playing diverse roles in health and disease. Interestingly, this modification is regulated by only two enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA).
openaire   +1 more source

O-GlcNAcase Is an RNA Polymerase II Elongation Factor Coupled to Pausing Factors SPT5 and TIF1β. [PDF]

open access: yesJ Biol Chem, 2016
Resto M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy